{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:10:39Z","timestamp":1790687439079,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aberrant NF-\u03baB activation is a hallmark of most B-cell malignancies. Recurrent inactivating somatic mutations in the<jats:italic>NFKBIE<\/jats:italic>gene, which encodes I\u03baB\u03b5, an inhibitor of NF-\u03baB-inducible activity, are reported in several B-cell malignancies with highest frequencies in chronic lymphocytic leukemia and primary mediastinal B-cell lymphoma, and account for a fraction of NF-\u03baB pathway activation. The impact of<jats:italic>NFKBIE<\/jats:italic>deficiency on B-cell development and function remains, however, largely unknown. Here, we show that<jats:italic>Nfkbie<\/jats:italic>-deficient mice exhibit an amplification of marginal zone B cells and an expansion of B1 B-cell subsets. In germinal center (GC)-dependent immune response,<jats:italic>Nfkbie<\/jats:italic>deficiency triggers expansion of GC B-cells through increasing cell proliferation in a B-cell autonomous manner. We also show that<jats:italic>Nfkbie<\/jats:italic>deficiency results in hyperproliferation of a B1 B-cell subset and leads to increased NF-\u03baB activation in these cells upon Toll-like receptor stimulation.<jats:italic>Nfkbie<\/jats:italic>deficiency cooperates with mutant MYD88 signaling and enhances B-cell proliferation in vitro. In aged mice,<jats:italic>Nfkbie<\/jats:italic>absence drives the development of an oligoclonal indolent B-cell lymphoproliferative disorders, resembling monoclonal B-cell lymphocytosis. Collectively, these findings shed light on an essential role of I\u03baB\u03b5 in finely tuning B-cell development and function.<\/jats:p>","DOI":"10.1038\/s41408-020-0305-6","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T17:03:00Z","timestamp":1584118980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7436-4304","authenticated-orcid":false,"given":"Veronique","family":"Della-Valle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Roos-Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurianne","family":"Scourzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enguerran","family":"Mouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakia","family":"Aid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Darwiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Lecluse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Damm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6571-4192","authenticated-orcid":false,"given":"Sylvie","family":"M\u00e9met","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mercher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6547-2664","authenticated-orcid":false,"given":"Said","family":"Aoufouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Nguyen-Khac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier A.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-1081","authenticated-orcid":false,"given":"Hussein","family":"Ghamlouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,13]]},"reference":[{"key":"305_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","volume":"168","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q., Lenardo, M. J. & Baltimore, D. 30 Years of NF-kappaB: a blossoming of relevance to human pathobiology. Cell 168, 37\u201357 (2017).","journal-title":"Cell"},{"key":"305_CR2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1084\/jem.20142009","volume":"212","author":"L Mansouri","year":"2015","unstructured":"Mansouri, L. et al. Functional loss of IkappaBepsilon leads to NF-kappaB deregulation in aggressive chronic lymphocytic leukemia. J. Exp. Med. 212, 833\u2013843 (2015).","journal-title":"J. Exp. Med."},{"key":"305_CR3","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/2159-8290.CD-14-0104","volume":"4","author":"F Damm","year":"2014","unstructured":"Damm, F. et al. Acquired initiating mutations in early hematopoietic cells of CLL patients. Cancer Discov. 4, 1088\u20131101 (2014).","journal-title":"Cancer Discov."},{"key":"305_CR4","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","volume":"194","author":"RE Davis","year":"2001","unstructured":"Davis, R. E., Brown, K. D., Siebenlist, U. & Staudt, L. M. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 194, 1861\u20131874 (2001).","journal-title":"J. Exp. Med."},{"key":"305_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nature07968","volume":"459","author":"M Compagno","year":"2009","unstructured":"Compagno, M. et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 459, 717\u2013721 (2009).","journal-title":"Nature"},{"key":"305_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ng.2856","volume":"46","author":"J Okosun","year":"2014","unstructured":"Okosun, J. et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat. Genet. 46, 176\u2013181 (2014).","journal-title":"Nat. Genet."},{"key":"305_CR7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","volume":"117","author":"Y Herishanu","year":"2011","unstructured":"Herishanu, Y. et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 117, 563\u2013574 (2011).","journal-title":"Blood"},{"key":"305_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.semcancer.2016.07.005","volume":"39","author":"L Mansouri","year":"2016","unstructured":"Mansouri, L., Papakonstantinou, N., Ntoufa, S., Stamatopoulos, K. & Rosenquist, R. NF-kappaB activation in chronic lymphocytic leukemia: a point of convergence of external triggers and intrinsic lesions. Sem. Cancer Biol. 39, 40\u201348 (2016).","journal-title":"Sem. Cancer Biol."},{"key":"305_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.45","volume":"3","author":"P Oppezzo","year":"2013","unstructured":"Oppezzo, P. & Dighiero, G. \u201cRole of the B-cell receptor and the microenvironment in chronic lymphocytic leukemia\u201d. Blood Cancer J. 3, e149 (2013).","journal-title":"Blood Cancer J."},{"key":"305_CR10","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz, R. et al. Genetics and pathogenesis of diffuse large B-cell lymphoma. N. Engl. J. Med. 378, 1396\u20131407 (2018).","journal-title":"N. Engl. J. Med."},{"key":"305_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","volume":"171","author":"A Reddy","year":"2017","unstructured":"Reddy, A. et al. Genetic and functional drivers of diffuse large B cell lymphoma. Cell 171, 481\u2013494 e415 (2017).","journal-title":"Cell"},{"key":"305_CR12","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1182\/blood-2016-03-704528","volume":"128","author":"L Mansouri","year":"2016","unstructured":"Mansouri, L. et al. Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma. Blood 128, 2666\u20132670 (2016).","journal-title":"Blood"},{"key":"305_CR13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/bjh.14719","volume":"178","author":"H Ghamlouch","year":"2017","unstructured":"Ghamlouch, H., Nguyen-Khac, F. & Bernard, O. A. Chronic lymphocytic leukaemia genomics and the precision medicine era. Br. J. Haematol. 178, 852\u2013870 (2017).","journal-title":"Br. J. Haematol."},{"key":"305_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038158","volume":"7","author":"E Domenech","year":"2012","unstructured":"Domenech, E. et al. New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing. PLoS ONE 7, e38158 (2012).","journal-title":"PLoS ONE"},{"key":"305_CR15","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/leu.2016.10","volume":"30","author":"MJ Rose-Zerilli","year":"2016","unstructured":"Rose-Zerilli, M. J. et al. Longitudinal copy number, whole exome and targeted deep sequencing of \u2018good risk\u2019 IGHV-mutated CLL patients with progressive disease. Leukemia 30, 1301\u20131310 (2016).","journal-title":"Leukemia"},{"key":"305_CR16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1182\/blood-2015-10-674572","volume":"127","author":"V Ljungstrom","year":"2016","unstructured":"Ljungstrom, V. et al. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations. Blood 127, 1007\u20131016 (2016).","journal-title":"Blood"},{"key":"305_CR17","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-15-2123","volume":"22","author":"RD Morin","year":"2016","unstructured":"Morin, R. D. et al. Genetic landscapes of relapsed and refractory diffuse large B-cell lymphomas. Clin. Cancer Res. 22, 2290\u20132300 (2016).","journal-title":"Clin. Cancer Res."},{"key":"305_CR18","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/emboj\/16.6.1413","volume":"16","author":"ST Whiteside","year":"1997","unstructured":"Whiteside, S. T., Epinat, J. C., Rice, N. R. & Israel, A. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J. 16, 1413\u20131426 (1997).","journal-title":"EMBO J."},{"key":"305_CR19","doi-asserted-by":"publisher","first-page":"14372","DOI":"10.1073\/pnas.94.26.14372","volume":"94","author":"S Simeonidis","year":"1997","unstructured":"Simeonidis, S., Liang, S., Chen, G. & Thanos, D. Cloning and functional characterization of mouse IkappaBepsilon. Proc. Natl Acad. Sci. USA 94, 14372\u201314377 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"305_CR20","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.4049\/jimmunol.1302351","volume":"192","author":"BN Alves","year":"2014","unstructured":"Alves, B. N. et al. IkappaBepsilon is a key regulator of B cell expansion by providing negative feedback on cRel and RelA in a stimulus-specific manner. J. Immunol. 192, 3121\u20133132 (2014).","journal-title":"J. Immunol."},{"key":"305_CR21","doi-asserted-by":"publisher","first-page":"983","DOI":"10.4049\/jimmunol.174.2.983","volume":"174","author":"S Doerre","year":"2005","unstructured":"Doerre, S. et al. Reductions in I kappa B epsilon and changes in NF-kappa B activity during B lymphocyte differentiation. J. Immunol. 174, 983\u2013991 (2005).","journal-title":"J. Immunol."},{"key":"305_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024504","volume":"6","author":"JM Clark","year":"2011","unstructured":"Clark, J. M. et al. Inhibitor of kappa B epsilon (IkappaBepsilon) is a non-redundant regulator of c-Rel-dependent gene expression in murine T and B cells. PLoS ONE 6, e24504 (2011).","journal-title":"PLoS ONE"},{"key":"305_CR23","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.4049\/jimmunol.163.11.5994","volume":"163","author":"S Memet","year":"1999","unstructured":"Memet, S. et al. IkappaBepsilon-deficient mice: reduction of one T cell precursor subspecies and enhanced Ig isotype switching and cytokine synthesis. J. Immunol. 163, 5994\u20136005 (1999).","journal-title":"J. Immunol."},{"key":"305_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","volume":"20","author":"C Quivoron","year":"2011","unstructured":"Quivoron, C. et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20, 25\u201338 (2011).","journal-title":"Cancer Cell"},{"key":"305_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1182\/bloodadvances.2017014118","volume":"2","author":"E Mouly","year":"2018","unstructured":"Mouly, E. et al. B-cell tumor development in Tet2-deficient mice. Blood Adv. 2, 703\u2013714 (2018).","journal-title":"Blood Adv."},{"key":"305_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1475","volume":"2","author":"T Nojima","year":"2011","unstructured":"Nojima, T. et al. In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo. Nat. Commun. 2, 465 (2011).","journal-title":"Nat. Commun."},{"key":"305_CR27","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1084\/jem.20091927","volume":"207","author":"JE Walter","year":"2010","unstructured":"Walter, J. E. et al. Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency. J. Exp. Med. 207, 1541\u20131554 (2010).","journal-title":"J. Exp. Med."},{"key":"305_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/nyas.12800","volume":"1362","author":"GK Pedersen","year":"2015","unstructured":"Pedersen, G. K., Adori, M. & Karlsson Hedestam, G. B. NF-kappaB signaling in B-1 cell development. Ann. NY Acad. Sci. 1362, 39\u201347 (2015).","journal-title":"Ann. NY Acad. Sci."},{"key":"305_CR29","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrc2759","volume":"9","author":"S Pillai","year":"2009","unstructured":"Pillai, S. & Cariappa, A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. 9, 767\u2013777 (2009).","journal-title":"Nat. Rev."},{"key":"305_CR30","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1126\/science.aau8475","volume":"363","author":"R Graf","year":"2019","unstructured":"Graf, R. et al. BCR-dependent lineage plasticity in mature B cells.Science 363, 748\u2013753 (2019).","journal-title":"Science"},{"key":"305_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/ni1301","volume":"7","author":"E Montecino-Rodriguez","year":"2006","unstructured":"Montecino-Rodriguez, E., Leathers, H. & Dorshkind, K. Identification of a B-1 B cell-specified progenitor. Nat. Immunol. 7, 293\u2013301 (2006).","journal-title":"Nat. Immunol."},{"key":"305_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/MOH.0000000000000160","volume":"22","author":"U Klein","year":"2015","unstructured":"Klein, U. & Heise, N. Unexpected functions of nuclear factor-kappaB during germinal center B-cell development: implications for lymphomagenesis. Curr. Opin. Hematol. 22, 379\u2013387 (2015).","journal-title":"Curr. Opin. Hematol."},{"key":"305_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0022-1759(03)00184-4","volume":"279","author":"LL Doan","year":"2003","unstructured":"Doan, L. L., Tanner, M. K. & Grimes, H. L. Intranuclear staining of proteins in heterogeneous cell populations and verification of nuclear localization by flow cytometric analysis. J. Immunol. Methods 279, 193\u2013198 (2003).","journal-title":"J. Immunol. Methods"},{"key":"305_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1158\/0008-5472.CAN-14-2814","volume":"76","author":"Y Shono","year":"2016","unstructured":"Shono, Y. et al. Characterization of a c-Rel inhibitor that mediates anticancer properties in hematologic malignancies by blocking NF-kappaB-controlled oxidative stress responses. Cancer Res. 76, 377\u2013389 (2016).","journal-title":"Cancer Res."},{"key":"305_CR35","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1158\/2159-8290.CD-18-0873","volume":"9","author":"D Roos-Weil","year":"2019","unstructured":"Roos-Weil, D. et al. A recurrent activating missense mutation in waldenstrom macroglobulinemia affects the DNA binding of the ETS transcription factor SPI1 and enhances proliferation. Cancer Discov. 9, 796\u2013811 (2019).","journal-title":"Cancer Discov."},{"key":"305_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature09671","volume":"470","author":"VN Ngo","year":"2011","unstructured":"Ngo, V. N. et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 470, 115\u2013119 (2011).","journal-title":"Nature"},{"key":"305_CR37","doi-asserted-by":"crossref","unstructured":"Fox, L. C. et al. Molecular mechanisms of disease progression in primary cutaneous diffuse large B-cell lymphoma, leg type during ibrutinib therapy. Int. J. Mol. Sci. 19 (2018).","DOI":"10.3390\/ijms19061758"},{"key":"305_CR38","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1182\/blood-2013-12-543306","volume":"123","author":"A Martinez-Trillos","year":"2014","unstructured":"Martinez-Trillos, A. et al. Mutations in TLR\/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome. Blood 123, 3790\u20133796 (2014).","journal-title":"Blood"},{"key":"305_CR39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/leu.2017.291","volume":"32","author":"F Nadeu","year":"2018","unstructured":"Nadeu, F. et al. Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia. Leukemia 32, 645\u2013653 (2018).","journal-title":"Leukemia"},{"key":"305_CR40","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1084\/jem.20131424","volume":"211","author":"JQ Wang","year":"2014","unstructured":"Wang, J. Q., Jeelall, Y. S., Beutler, B., Horikawa, K. & Goodnow, C. C. Consequences of the recurrent MYD88(L265P) somatic mutation for B cell tolerance. J. Exp. Med. 211, 413\u2013426 (2014).","journal-title":"J. Exp. Med."},{"key":"305_CR41","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41586-018-0290-0","volume":"560","author":"JD Phelan","year":"2018","unstructured":"Phelan, J. D. et al. A multiprotein supercomplex controlling oncogenic signalling in lymphoma. Nature 560, 387\u2013391 (2018).","journal-title":"Nature"},{"key":"305_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002949","volume":"8","author":"K Myouzen","year":"2012","unstructured":"Myouzen, K. et al. Functional variants in NFKBIE and RTKN2 involved in activation of the NF-kappaB pathway are associated with rheumatoid arthritis in Japanese. PLoS Genet. 8, e1002949 (2012).","journal-title":"PLoS Genet."},{"key":"305_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ebiom.2015.11.048","volume":"3","author":"LF Lundbo","year":"2015","unstructured":"Lundbo, L. F. et al. Genetic variation in NFKBIE is associated with increased risk of pneumococcal meningitis in children. EBioMedicine 3, 93\u201399 (2015).","journal-title":"EBioMedicine"},{"key":"305_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.semcancer.2016.07.001","volume":"39","author":"S Ntoufa","year":"2016","unstructured":"Ntoufa, S., Vilia, M. G., Stamatopoulos, K., Ghia, P. & Muzio, M. Toll-like receptors signaling: a complex network for NF-kappaB activation in B-cell lymphoid malignancies. Sem. Cancer Biol. 39, 15\u201325 (2016).","journal-title":"Sem. Cancer Biol."},{"key":"305_CR45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/nyas.12768","volume":"1362","author":"K Hayakawa","year":"2015","unstructured":"Hayakawa, K. et al. B cells generated by B-1 development can progress to chronic lymphocytic leukemia. Ann. NY Acad. Sci. 1362, 250\u2013255 (2015).","journal-title":"Ann. NY Acad. Sci."},{"key":"305_CR46","doi-asserted-by":"crossref","unstructured":"Kreuk, L. S. et al. B cell receptor and Toll-like receptor signaling coordinate to control distinct B-1 responses to both self and the microbiota. eLife 8 (2019).","DOI":"10.7554\/eLife.47015"},{"key":"305_CR47","doi-asserted-by":"crossref","unstructured":"Savage, H. P. et al. TLR induces reorganization of the IgM-BCR complex regulating murine B-1 cell responses to infections. eLife 8 (2019).","DOI":"10.7554\/eLife.46997"},{"key":"305_CR48","doi-asserted-by":"publisher","first-page":"12145","DOI":"10.1073\/pnas.1516428112","volume":"112","author":"KL Otipoby","year":"2015","unstructured":"Otipoby, K. L. et al. The B-cell antigen receptor integrates adaptive and innate immune signals. Proc. Natl Acad. Sci. USA 112, 12145\u201312150 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"305_CR49","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1084\/jem.20161117","volume":"214","author":"E Schweighoffer","year":"2017","unstructured":"Schweighoffer, E., Nys, J., Vanes, L., Smithers, N. & Tybulewicz, V. L. J. TLR4 signals in B lymphocytes are transduced via the B cell antigen receptor and SYK. J. Exp. Med. 214, 1269\u20131280 (2017).","journal-title":"J. Exp. Med."},{"key":"305_CR50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nature11311","volume":"489","author":"J Zikherman","year":"2012","unstructured":"Zikherman, J., Parameswaran, R. & Weiss, A. Endogenous antigen tunes the responsiveness of naive B cells but not T cells. Nature 489, 160\u2013164 (2012).","journal-title":"Nature"},{"key":"305_CR51","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/352532a0","volume":"352","author":"CC Goodnow","year":"1991","unstructured":"Goodnow, C. C., Brink, R. & Adams, E. Breakdown of self-tolerance in anergic B lymphocytes. Nature 352, 532\u2013536 (1991).","journal-title":"Nature"},{"key":"305_CR52","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1084\/jem.191.5.883","volume":"191","author":"KL Hippen","year":"2000","unstructured":"Hippen, K. L., Tze, L. E. & Behrens, T. W. CD5 maintains tolerance in anergic B cells. J. Exp. Med. 191, 883\u2013890 (2000).","journal-title":"J. Exp. Med."},{"key":"305_CR53","first-page":"633","volume":"7","author":"JC Cambier","year":"2007","unstructured":"Cambier, J. C., Gauld, S. B., Merrell, K. T. & Vilen, B. J. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat. Rev. 7, 633\u2013643 (2007).","journal-title":"Nat. Rev."},{"key":"305_CR54","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3389\/fimmu.2018.00683","volume":"9","author":"W Darwiche","year":"2018","unstructured":"Darwiche, W., Gubler, B., Marolleau, J. P. & Ghamlouch, H. Chronic lymphocytic leukemia B-cell normal cellular counterpart: clues from a functional perspective. Front. Immunol. 9, 683 (2018).","journal-title":"Front. Immunol."},{"key":"305_CR55","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ni1256","volume":"6","author":"SB Gauld","year":"2005","unstructured":"Gauld, S. B., Benschop, R. J., Merrell, K. T. & Cambier, J. C. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat. Immunol. 6, 1160\u20131167 (2005).","journal-title":"Nat. Immunol."},{"key":"305_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.77","volume":"7","author":"IV Kostopoulos","year":"2017","unstructured":"Kostopoulos, I. V. et al. Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis. Blood Cancer J. 7, e597 (2017).","journal-title":"Blood Cancer J."},{"key":"305_CR57","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/nyas.12825","volume":"1362","author":"NE Holodick","year":"2015","unstructured":"Holodick, N. E. & Rothstein, T. L. B cells in the aging immune system: time to consider B-1 cells. Ann. NY Acad. Sci. 1362, 176\u2013187 (2015).","journal-title":"Ann. NY Acad. Sci."},{"key":"305_CR58","doi-asserted-by":"crossref","unstructured":"Bodogai, M. et al. Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells. Sci. Transl. Med. 10 (2018).","DOI":"10.1126\/scitranslmed.aat4271"},{"key":"305_CR59","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12185-014-1651-6","volume":"100","author":"Y Kikushige","year":"2014","unstructured":"Kikushige, Y. & Miyamoto, T. Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis. Int. J. Hematol. 100, 335\u2013340 (2014).","journal-title":"Int. J. Hematol."},{"key":"305_CR60","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1084\/jem.20160712","volume":"213","author":"K Hayakawa","year":"2016","unstructured":"Hayakawa, K. et al. Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression. J. Exp. Med. 213, 3007\u20133024 (2016).","journal-title":"J. Exp. Med."},{"key":"305_CR61","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/leu.2016.61","volume":"30","author":"K Hayakawa","year":"2016","unstructured":"Hayakawa, K. et al. Loss of a chromosomal region with synteny to human 13q14 occurs in mouse chronic lymphocytic leukemia that originates from early-generated B-1 B cells. Leukemia 30, 1510\u20131519 (2016).","journal-title":"Leukemia"},{"key":"305_CR62","doi-asserted-by":"publisher","first-page":"804","DOI":"10.4049\/jimmunol.1800400","volume":"201","author":"K Hayakawa","year":"2018","unstructured":"Hayakawa, K. et al. Early generated B-1-derived B cells have the capacity to progress to become mantle cell lymphoma-like neoplasia in aged mice. J. Immunol. 201, 804\u2013813 (2018).","journal-title":"J. Immunol."},{"key":"305_CR63","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1084\/jem.20132613","volume":"211","author":"N Heise","year":"2014","unstructured":"Heise, N. et al. Germinal center B cell maintenance and differentiation are controlled by distinct NF-kappaB transcription factor subunits. J. Exp. Med. 211, 2103\u20132118 (2014).","journal-title":"J. Exp. Med."},{"key":"305_CR64","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1084\/jem.20180230","volume":"215","author":"MN Wray-Dutra","year":"2018","unstructured":"Wray-Dutra, M. N. et al. Activated CARD11 accelerates germinal center kinetics, promoting mTORC1 and terminal differentiation. J. Exp. Med. 215, 2445\u20132461 (2018).","journal-title":"J. Exp. Med."},{"key":"305_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0130-3","volume":"8","author":"K Wenzl","year":"2018","unstructured":"Wenzl, K. et al. Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma. Blood Cancer J. 8, 97 (2018).","journal-title":"Blood Cancer J."},{"key":"305_CR66","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1158\/0008-5472.CAN-08-3701","volume":"69","author":"E Braggio","year":"2009","unstructured":"Braggio, E. et al. Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom\u2019s macroglobulinemia. Cancer Res. 69, 3579\u20133588 (2009).","journal-title":"Cancer Res."}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-020-0305-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-020-0305-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-020-0305-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T16:40:35Z","timestamp":1695919235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-020-0305-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,13]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["305"],"URL":"https:\/\/doi.org\/10.1038\/s41408-020-0305-6","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,13]]},"assertion":[{"value":"22 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"38"}}